Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynaecology,Oncology
Reference29 articles.
1. Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines;Dai;Clin. Cancer Res.,2005
2. New guidelines to evaluate the response to treatment in solid tumors;Vergote;J. Natl. Cancer Inst.,2000
3. Reactivity of a monoclonal antibody with human ovarian carcinoma;Bast;J. Clin. Invest.,1981
4. Ovarian cancer antigen CA-125 is encoded by the MUC16 mucin gene;Yin;Int. J. Cancer,2002
5. Tumor markers in the management of patients with ovarian cancer;Tuxen;Cancer Treat Rev.,1995
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer;Cells;2021-08-27
2. Efficacy of Huaier granule in patients with breast cancer;Clinical and Translational Oncology;2018-10-01
3. Challenges in Optimising the Successful Construction of Antibody Drug Conjugates in Cancer Therapy;Antibodies;2018-02-13
4. Cancer Immunotherapy;Comprehensive Medicinal Chemistry III;2017
5. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium;Biological Chemistry;2014-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3